Skip to content
  • Sunday, 26 July 2026
  • 1:48 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Eli Lilly Commits Up to $3.8 Billion to Acquire AtaiBeckley, Betting on the ‘God Molecule’ 5-MeO-DMT for Transformative Mental Healthcare
Laboratory Automation & Robotics

Eli Lilly Commits Up to $3.8 Billion to Acquire AtaiBeckley, Betting on the ‘God Molecule’ 5-MeO-DMT for Transformative Mental Healthcare

Lana Keisha Jul 24, 2026 0

Indianapolis, IN – Pharmaceutical giant Eli Lilly has announced a definitive agreement to acquire AtaiBeckley, a clinical-stage biotechnology company focused…

Read More
Environmental & Analytical Chemistry

The Alarming Rise of AI Chatbots in Youth Mental Healthcare: A Silent Epidemic

Abdurrohim Arsyad Jun 1, 2026 0

A growing number of adolescents and young adults are turning to artificial intelligence chatbots for mental health support, a trend…

Read More
Pharmaceutical R&D

The Strait of Hormuz Blockades Ignite Global Healthcare Cost Crisis and Exacerbate Inequality

Teuku Ryan May 28, 2026 0

Ongoing geopolitical tensions and trade disruptions emanating from the Strait of Hormuz are precipitating a severe and escalating global healthcare…

Read More
Pharmaceutical R&D

Merative MarketScan Podcast Launches Season Two Exploring Real-World Healthcare Costs

Teuku Ryan May 26, 2026 0

The second season of the Merative MarketScan podcast has commenced, with its inaugural episode delving into the intricate and often…

Read More
Clinical Diagnostics & Pathology

Walk-in Lab Testing in West Virginia Accelerates Consumer-Driven Healthcare, Reshaping Diagnostic Access and Clinical Laboratory Models

Reynand Amr Wu May 24, 2026 0

The landscape of healthcare diagnostics is undergoing a profound transformation, with West Virginia emerging as a key region illustrating this…

Read More
Pharmaceutical R&D

Global Healthcare Giants Unite: GHO Capital and CBC Group Forge Largest Dedicated Investment Manager with $21 Billion AUM

Teuku Ryan May 20, 2026 0

Two prominent forces in specialized healthcare investment, Global Healthcare Opportunities (GHO) and CBC Group, have announced a groundbreaking merger to…

Read More
Pharmaceutical R&D

Novartis Breaks Ground on New Radioligand Therapy Manufacturing Facility in Denton, Texas, Bolstering US Healthcare Infrastructure

Teuku Ryan May 9, 2026 0

Novartis has commenced construction on a significant new radioligand therapy (RLT) manufacturing facility in Denton, Texas, a pivotal development in…

Read More
Clinical Diagnostics & Pathology

Walk-in Lab Testing in West Virginia Signals a National Shift Toward Consumer-Directed Healthcare

Reynand Amr Wu May 2, 2026 0

The landscape of diagnostic services in West Virginia is undergoing a transformative shift, with the proliferation of walk-in laboratory testing…

Read More
Clinical Diagnostics & Pathology

Walk-in Lab Testing in West Virginia Accelerates Consumer-Driven Healthcare, Reshaping Diagnostic Access and Clinical Lab Models

Reynand Amr Wu Apr 3, 2026 0

The landscape of healthcare diagnostics is undergoing a profound transformation, with walk-in lab testing emerging as a pivotal force in…

Read More
Clinical Diagnostics & Pathology

LinkedIn Report Unveils Critical Skills Driving the Future of Clinical Laboratory Careers Amidst Evolving Healthcare Landscape

Reynand Amr Wu Mar 27, 2026 0

A groundbreaking analysis from LinkedIn’s latest "Skills on the Rise" report has cast a revealing light on the rapidly transforming…

Read More
Exploring the Top 10 Agentic AI Frameworks Shaping Development in 2026TWiV 1285: Encapsidating Viruses 2025Novel Combination Therapy CagriSema Demonstrates Promising Results in Obesity Management with Preserved Muscle StrengthGinkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ